Page 96 - AN-1-2

Advanced Neurology Neurological complications of COVID-19

case of meningitis/encephalitis associated with SARS- 76. Prather KA, Wang CC, Schooley RT. 2020, Reducing
Coronavirus-2. Int J Infect Dis, 94:55–58. transmission of SARS-CoV-2. Science, 368(6498): 1422–1424.
https://doi.org/10.1016/j.ijid.2020.03.062 https://doi.org/10.1126/science.abc6197
66. Mardani M, Nadji SA, Sarhangipor KA, et al., 2020, 77. Mehta P, McAuley DF, Brown M, et al., 2020,
COVID-19 infection recurrence presenting with COVID-19: Consider cytokine storm syndromes and
meningoencephalitis. New Microbes New Infect, 37: 100372. immunosuppression. Lancet, 395(10229): 1033–1034.
https://doi.org/10.1016/j.nmni.2020.100732 https://doi.org/10.1016/S0140-6736(20)30628-0
67. Bernard-Valnet R, Pizzarotti B, Anichini A, et al., 2020, Two 78. Adhikary A, Halder K, Ghosh D, et al., 2020, A review of
patients with acute meningo-encephalitis concomitant to anti-inflammatory drugs use in the treatment of people
SARS-CoV-2 infection. Eur J Neurol, 27(9): e43–e44. infected by coronavirus disease 2019 (COVID-19). Acta Sci
https://doi.org/10.1111/ene.14298 Microbiol, 3: 28-34.
68. Kaya Y, Kara S, Akinci C, et al., 2020, Transient cortical https://doi.org/10.31080/ASMI.2020.03.0712
blindness in COVID-19 pneumonia; a PRES-like syndrome: 79. Durrant DM, Ghosh S, Klein RS, 2016, The olfactory bulb:
Case report. J Neurol Sci, 413: 116858. An immunosensory effector organ during neurotropic viral
https://doi.org/10.1016/j.jns.2020.116858 infections. Acs Chem Neurosci, 7(4): 464–469.
69. Papri N, Hayat S, Mohammed A, et al., 2021, Guillain-Barré https://doi.org/10.1021/acschemneuro.6b00043
syndrome associated with SARS-CoV-2 infection: A case 80. Netland J, Meyerholz DK, Moore S, et al., 2008, Severe acute
report with long term follow up. J Neuroimmunol, 356(8): respiratory syndrome coronavirus infection causes neuronal
577590. death in the absence of encephalitis in mice transgenic for
https://doi.org/10.1016/j.jneuroim.2021.577590 human ACE2. J Virol, 82(15): 7264–7275.
70. Tiet MY, Alshaikh N, 2020, Guillain-Barré syndrome https://doi.org/10.1128/JVI.00737-08
associated with COVID-19 infection: A case from the UK. 81. Amirian ES. 2020, Potential fecal transmission of SARS-
BMJ Case Rep, 13(7): e236536. CoV-2: Current evidence and implications for public health.
https://doi.org/10.1136/bcr-2020-236536 Int J Infect Dis, 95: 363–370.
71. Lascano AM, Epiney JB, Coen M, et al., 2020, SARS- https://doi.org/10.1016/j.ijid.2020.04.057
CoV-2 and Guillain-Barre syndrome: AIDP variant with a 82. Ahmed MU, Hanif M, Ali MJ, et al., 2020, Neurological
favourable outcome. Eur J Neurol, 27(9): 1751-1753. manifestations of COVID-19 (SARS-CoV-2): A review.
https://doi.org/10.1111/ene.14368 Front Neurol, 11: 518.
72. Carod-Artal FJ, 2020, Neurological complications of https://doi.org/10.3389/fneur.2020.00518
coronavirus and COVID-19. Rev Neurol, 70(9): 311–322. 83. Ludvigsson JF, 2022, Convulsions in children with COVID-19
https://doi.org/10.33588/rn.7009.2020179 during the Omicron wave. Acta Paediatr, 111(5): 1023–1026.
73. Desforges M, Coupanec AL, Brison E, et al., 2014, https://doi.org/10.1111/apa.16276
Neuroinvasive and neurotropic human respiratory 84. Thongsing A, Eizadkhah D, Fields C, et al., 2022, Provoked
coronaviruses: Potential neurovirulent agents in humans. seizures and status epilepticus in a pediatric population with
Adv Exp Med Biol, 807: 75–96.
COVID-19 disease. Epilepsia 10: 1111.
74. Zhou Z, Kang H, Li S, et al., 2020, Understanding the https://doi.org/10.1111/epi.17293
neurotropic characteristics of SARS-CoV-2: From
neurological manifestations of COVID-19 to potential 85. Pinzon RT, Wijaya VO, Buana RB, et al., 2020, Neurologic
neurotropic mechanisms. J Neurol, 267(10223): 2179–2184. characteristics in coronavirus disease 2019 (COVID-19):
A systematic review and meta-analysis. Front Neurol, 11: 565.
https://doi.org/10.1007/s00415-020-09929-7
https://doi.org/10.3389/fneur.2020.00565
75. Desforges M, Coupanec AL, Dubeau P, et al., 2019, Human
coronaviruses and other respiratory viruses: Underestimated 86. Collantes M, Espiritu AI, Sy MC, et al., 2021, Neurological
opportunistic pathogens of the central nervous system? manifestations in COVID-19 infection: A systematic review
Viruses, 12(1): 14. and meta-analysis. Can J Neurol Sci, 48(1): 66–76.
https://doi.org/10.3390/v12010014 https://doi.org/10.1017/cjn.2020.146

Volume 1 Issue 2 (2022) 10 https://doi.org/10.36922/an.v1i2.83